# Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia

> **NCT06624696** · PHASE4 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 204 (estimated)

## Conditions studied

- Respiratory Hypersensitivity
- Perioperative Respiratory Adverse Events
- Anticholinergics
- Inhalation Therapy; Complications
- High Risk

## Interventions

- **DRUG:** Penehyclidine hydrochloride
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT06624696
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-12
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-09-30
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06624696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06624696, "Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06624696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*